|
1
|
Samuel CS, Bodaragama H, Chew JY, Widdop RE, Royce SG, Hewitson TD. Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease. Hypertension 2014; 64:315-22. [DOI: 10.1161/hypertensionaha.114.03594] [Citation(s) in RCA: 67] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Affiliation(s)
- Chrishan S. Samuel
- From the Department of Pharmacology, Monash University, Melbourne, Victoria, Australia (C.S.S., H.B., J.Y.C., R.E.W., S.G.R.); Neuropeptides Division, Florey Institute of Neuroscience and Mental Health (C.S.S.) and Department of Biochemistry and Molecular Biology (C.S.S.), University of Melbourne, Melbourne, Victoria, Australia; Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia (T.D.H.); and Department of Medicine, University of Melbourne, Royal Melbourne Hospital,
| | - Hasangika Bodaragama
- From the Department of Pharmacology, Monash University, Melbourne, Victoria, Australia (C.S.S., H.B., J.Y.C., R.E.W., S.G.R.); Neuropeptides Division, Florey Institute of Neuroscience and Mental Health (C.S.S.) and Department of Biochemistry and Molecular Biology (C.S.S.), University of Melbourne, Melbourne, Victoria, Australia; Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia (T.D.H.); and Department of Medicine, University of Melbourne, Royal Melbourne Hospital,
| | - Jacqueline Y. Chew
- From the Department of Pharmacology, Monash University, Melbourne, Victoria, Australia (C.S.S., H.B., J.Y.C., R.E.W., S.G.R.); Neuropeptides Division, Florey Institute of Neuroscience and Mental Health (C.S.S.) and Department of Biochemistry and Molecular Biology (C.S.S.), University of Melbourne, Melbourne, Victoria, Australia; Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia (T.D.H.); and Department of Medicine, University of Melbourne, Royal Melbourne Hospital,
| | - Robert E. Widdop
- From the Department of Pharmacology, Monash University, Melbourne, Victoria, Australia (C.S.S., H.B., J.Y.C., R.E.W., S.G.R.); Neuropeptides Division, Florey Institute of Neuroscience and Mental Health (C.S.S.) and Department of Biochemistry and Molecular Biology (C.S.S.), University of Melbourne, Melbourne, Victoria, Australia; Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia (T.D.H.); and Department of Medicine, University of Melbourne, Royal Melbourne Hospital,
| | - Simon G. Royce
- From the Department of Pharmacology, Monash University, Melbourne, Victoria, Australia (C.S.S., H.B., J.Y.C., R.E.W., S.G.R.); Neuropeptides Division, Florey Institute of Neuroscience and Mental Health (C.S.S.) and Department of Biochemistry and Molecular Biology (C.S.S.), University of Melbourne, Melbourne, Victoria, Australia; Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia (T.D.H.); and Department of Medicine, University of Melbourne, Royal Melbourne Hospital,
| | - Tim D. Hewitson
- From the Department of Pharmacology, Monash University, Melbourne, Victoria, Australia (C.S.S., H.B., J.Y.C., R.E.W., S.G.R.); Neuropeptides Division, Florey Institute of Neuroscience and Mental Health (C.S.S.) and Department of Biochemistry and Molecular Biology (C.S.S.), University of Melbourne, Melbourne, Victoria, Australia; Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria, Australia (T.D.H.); and Department of Medicine, University of Melbourne, Royal Melbourne Hospital,
| |
Collapse
|